NO20031693L - Nye anticholinerge midler som kan anvendes som medikamenter og fremgangsmåte for fremstilling av disse - Google Patents
Nye anticholinerge midler som kan anvendes som medikamenter og fremgangsmåte for fremstilling av disseInfo
- Publication number
- NO20031693L NO20031693L NO20031693A NO20031693A NO20031693L NO 20031693 L NO20031693 L NO 20031693L NO 20031693 A NO20031693 A NO 20031693A NO 20031693 A NO20031693 A NO 20031693A NO 20031693 L NO20031693 L NO 20031693L
- Authority
- NO
- Norway
- Prior art keywords
- medicaments
- preparation
- methods
- anticholinergic agents
- new anticholinergic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10050994A DE10050994A1 (de) | 2000-10-14 | 2000-10-14 | Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung |
| PCT/EP2001/011226 WO2002032899A1 (de) | 2000-10-14 | 2001-09-28 | Neue als arzneimittel einsetzbare anticholinergika sowie verfahren zu deren herstellung |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20031693D0 NO20031693D0 (no) | 2003-04-11 |
| NO20031693L true NO20031693L (no) | 2003-05-28 |
| NO328207B1 NO328207B1 (no) | 2010-01-11 |
Family
ID=7659808
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20031693A NO328207B1 (no) | 2000-10-14 | 2003-04-11 | Nye anticholinerge midler som kan anvendes som medikamenter og fremgangsmate for fremstilling av disse |
Country Status (38)
| Country | Link |
|---|---|
| EP (2) | EP1382606A3 (no) |
| JP (2) | JP4109106B2 (no) |
| KR (1) | KR100830359B1 (no) |
| CN (1) | CN1275962C (no) |
| AR (1) | AR035589A1 (no) |
| AT (1) | ATE259805T1 (no) |
| AU (2) | AU1397502A (no) |
| BG (1) | BG66225B1 (no) |
| BR (1) | BR0114635A (no) |
| CA (1) | CA2425557C (no) |
| DE (2) | DE10050994A1 (no) |
| DK (1) | DK1325001T3 (no) |
| EA (1) | EA005816B1 (no) |
| EC (1) | ECSP034542A (no) |
| EE (1) | EE05179B1 (no) |
| ES (1) | ES2215147T3 (no) |
| HK (1) | HK1060566A1 (no) |
| HR (1) | HRP20030278B1 (no) |
| HU (1) | HUP0301203A3 (no) |
| IL (2) | IL155334A0 (no) |
| ME (1) | MEP39908A (no) |
| MX (1) | MXPA03003160A (no) |
| MY (1) | MY127144A (no) |
| NO (1) | NO328207B1 (no) |
| NZ (1) | NZ525836A (no) |
| PE (1) | PE20020433A1 (no) |
| PL (1) | PL207311B1 (no) |
| PT (1) | PT1325001E (no) |
| RS (1) | RS50464B (no) |
| SA (1) | SA01220414B1 (no) |
| SI (1) | SI1325001T1 (no) |
| SK (1) | SK287138B6 (no) |
| TR (1) | TR200400376T4 (no) |
| TW (1) | TWI306098B (no) |
| UA (1) | UA73804C2 (no) |
| UY (1) | UY26958A1 (no) |
| WO (1) | WO2002032899A1 (no) |
| ZA (1) | ZA200302914B (no) |
Families Citing this family (79)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10200943A1 (de) * | 2002-01-12 | 2003-07-24 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung von Scopinestern |
| DE10203753A1 (de) * | 2002-01-31 | 2003-08-14 | Boehringer Ingelheim Pharma | Neue Xanthencarbonsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
| US7405224B2 (en) | 2002-01-31 | 2008-07-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Xanthenecarboxylates, processes for preparing them, and their use as pharmaceutical compositions |
| US7084153B2 (en) | 2002-04-12 | 2006-08-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments comprising steroids and a novel anticholinergic |
| DE10216429A1 (de) * | 2002-04-12 | 2003-10-23 | Boehringer Ingelheim Pharma | Arzneimittel enthaltend Steroide und ein neues Anticholinergikum |
| WO2003087097A1 (de) * | 2002-04-12 | 2003-10-23 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Arzneimittel enthaltend betamimetika und ein neues anticholinergikum |
| US7417051B2 (en) | 2002-04-12 | 2008-08-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments comprising betamimetics and a novel anticholinergic |
| DE10256317A1 (de) * | 2002-04-12 | 2003-10-23 | Boehringer Ingelheim Pharma | Arzneimittel enthaltend Betamimetika und ein neues Anticholinergikum |
| DE10224091A1 (de) * | 2002-05-31 | 2003-12-11 | Boehringer Ingelheim Pharma | Technisches Verfahren zur Herstellung von Tropenol |
| DE10230750A1 (de) * | 2002-07-09 | 2004-01-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittelkompositionen auf der Basis neuer Anticholonergika und NK1-Rezeptor-Antagonisten |
| AU2003245989A1 (en) * | 2002-07-09 | 2004-01-23 | Boehringer Ingelheim Pharma Gmbh And Co. Kg | Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
| DE10230769A1 (de) * | 2002-07-09 | 2004-01-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und PDE-IV-Inhibitoren |
| DE10230751A1 (de) | 2002-07-09 | 2004-01-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und EGFR-Kinase-Hemmern |
| NZ538743A (en) * | 2002-08-14 | 2006-05-26 | Boehringer Ingelheim Pharma | Aerosol formulation for inhalation containing an anticholinergic agent |
| DE10237739A1 (de) * | 2002-08-17 | 2004-02-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika |
| US7244742B2 (en) | 2002-08-17 | 2007-07-17 | Boehringer Ingelheim Pharma Gmbh & Co Kg | Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic |
| US7056916B2 (en) | 2002-11-15 | 2006-06-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
| DE10317461A1 (de) | 2003-04-16 | 2004-10-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung |
| DE10323966A1 (de) * | 2003-05-27 | 2004-12-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue langwirksame Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen |
| US7332175B2 (en) | 2003-05-27 | 2008-02-19 | Boehringer Ingelheim International Gmbh | Long-acting drug combinations for the treatment of respiratory complaints |
| US7273603B2 (en) | 2003-07-11 | 2007-09-25 | Boehringer Ingelheim International Gmbh | HFC solution formulations containing an anticholinergic |
| DE10331350A1 (de) * | 2003-07-11 | 2005-01-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pulverformulierungen für die Inhalation enthaltend ein neues Anticholinergikum |
| US7462367B2 (en) | 2003-07-11 | 2008-12-09 | Boehringer Ingelheim International Gmbh | Anticholinergic powder formulations for inhalation |
| EP1651230B1 (en) * | 2003-07-28 | 2009-07-01 | Boehringer Ingelheim International GmbH | Medicaments for inhalation comprising steroids and a novel fluorene carboxylic acid ester |
| WO2005013967A1 (en) * | 2003-07-28 | 2005-02-17 | Boehringer Ingelheim International Gmbh | Medicaments comprising pde iv inhibitors and a novel anticholinergic and their use for treating respiratory disorders |
| EP1651221B1 (en) * | 2003-07-28 | 2009-01-14 | Boehringer Ingelheim International Gmbh | Medicaments for inhalation comprising betamimetics and an anticholinergic agent |
| ATE526967T1 (de) * | 2003-07-31 | 2011-10-15 | Boehringer Ingelheim Int | Medikamente für inhalationen enthaltend ein anticholinergikum und ein betamimetikum |
| EP1504756A1 (en) * | 2003-08-06 | 2005-02-09 | Kyowa Hakko Kogyo Co., Ltd | Medicament compositions comprising a heterocyclic compound and an anticholinergic |
| DE10345065A1 (de) * | 2003-09-26 | 2005-04-14 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum |
| WO2005067929A1 (en) * | 2004-01-09 | 2005-07-28 | Boehringer Ingelheim International Gmbh | New pharmaceutical compositions based on a scopineester and nicotinamide derivatives |
| US20050186175A1 (en) * | 2004-02-20 | 2005-08-25 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions based on benzilic acid esters and soluble TNF receptor fusion proteins |
| CA2552903A1 (en) * | 2004-02-20 | 2005-09-01 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions based on anticholinergics and pegsunercept |
| US7507745B2 (en) | 2004-02-20 | 2009-03-24 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions based on fluorenecarboxylic acid esters and soluble TNF receptor fusion proteins |
| DE102004016179A1 (de) * | 2004-03-30 | 2005-10-20 | Boehringer Ingelheim Pharma | Verbindungen zur Behandlung von proliferativen Prozessen |
| US7220742B2 (en) | 2004-05-14 | 2007-05-22 | Boehringer Ingelheim International Gmbh | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments |
| ES2322148T3 (es) * | 2004-08-11 | 2009-06-17 | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG | Medicamentos que contienen anticolinergicos para el tratamiento en las vias urinarias. |
| DE102004056578A1 (de) * | 2004-11-23 | 2006-05-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Formoterol und ein Steroid |
| CA2597942A1 (en) * | 2005-02-16 | 2006-08-24 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions comprising anticholinergics and etiprednol |
| EP1858554A2 (en) * | 2005-03-09 | 2007-11-28 | Boehringer Ingelheim International GmbH | New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors |
| EP1893203A2 (en) * | 2005-05-31 | 2008-03-05 | Boehringer Ingelheim International GmbH | Medicament containing a betamimetic in conjunction with an anticholinergic and a pde iv inhibitor |
| EP1898894A1 (en) * | 2005-06-17 | 2008-03-19 | Boehringer Ingelheim International GmbH | Mrp iv inhibitors for the treatment of respiratory diseases |
| DE102005030733A1 (de) | 2005-07-01 | 2007-01-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff |
| MX2008001976A (es) | 2005-08-15 | 2008-03-25 | Boehringer Ingelheim Int | Procedimiento para la preparacion de betamimeticos. |
| CA2626612A1 (en) | 2005-10-19 | 2007-04-26 | Ranbaxy Laboratories Limited | Pharmaceutical compositions of muscarinic receptor antagonists |
| DE102005055961A1 (de) * | 2005-11-24 | 2007-05-31 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum |
| DE102005055963A1 (de) * | 2005-11-24 | 2007-07-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum |
| DE102005055957A1 (de) * | 2005-11-24 | 2007-07-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum |
| ATE505193T1 (de) | 2006-08-07 | 2011-04-15 | Boehringer Ingelheim Int | Arzneimittelkombinationen zur behandlung von atemwegserkrankungen |
| EP1958947A1 (en) | 2007-02-15 | 2008-08-20 | Ranbaxy Laboratories Limited | Inhibitors of phosphodiesterase type 4 |
| CN103497185A (zh) | 2007-03-14 | 2014-01-08 | 兰贝克赛实验室有限公司 | 用作磷酸二酯酶抑制剂的吡唑并(3,4-b)吡啶衍生物 |
| EP2011538B1 (en) | 2007-07-06 | 2016-02-17 | Vectura Delivery Devices Limited | Inhaler |
| CA2688669A1 (en) * | 2007-07-18 | 2009-01-22 | Boehringer Ingelheim International Gmbh | New combinations for the treatment of respiratory diseases |
| EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
| EP2082767A1 (en) | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Inhaler |
| EP2082768A1 (en) | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Inhaler |
| EP2082766A1 (en) | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Blister Strip Coil Forming |
| EP2082771A1 (en) | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Inhaler |
| EP2082772A1 (en) | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Inhaler |
| EP2111861A1 (en) | 2008-04-21 | 2009-10-28 | Ranbaxy Laboratories Limited | Compositions of phosphodiesterase type IV inhibitors |
| JP5670421B2 (ja) | 2009-03-31 | 2015-02-18 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | コンポーネント表面のコーティング方法 |
| EP2432531B1 (de) | 2009-05-18 | 2019-03-06 | Boehringer Ingelheim International GmbH | Adapter, inhalationseinrichtung und zerstäuber |
| GB0918450D0 (en) | 2009-10-21 | 2009-12-09 | Innovata Ltd | Composition |
| US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
| JP5715640B2 (ja) | 2009-11-25 | 2015-05-13 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネブライザ |
| EP2504051B1 (en) | 2009-11-25 | 2019-09-04 | Boehringer Ingelheim International GmbH | Nebulizer |
| US9943654B2 (en) | 2010-06-24 | 2018-04-17 | Boehringer Ingelheim International Gmbh | Nebulizer |
| EP2694220B1 (de) | 2011-04-01 | 2020-05-06 | Boehringer Ingelheim International GmbH | Medizinisches gerät mit behälter |
| US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2013152894A1 (de) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Zerstäuber mit kodiermitteln |
| ES2706757T3 (es) | 2012-12-21 | 2019-04-01 | Boehringer Ingelheim Vetmedica Gmbh | Formulación farmacéutica que comprende ciclesonida |
| LT2934479T (lt) | 2012-12-21 | 2018-12-27 | Boehringer Ingelheim Vetmedica Gmbh | Ciklezonidas, skirtas arklių kvėpavimo takų ligų gydymui |
| EP3030298B1 (en) | 2013-08-09 | 2017-10-11 | Boehringer Ingelheim International GmbH | Nebulizer |
| ES2836977T3 (es) | 2013-08-09 | 2021-06-28 | Boehringer Ingelheim Int | Nebulizador |
| PL3139984T3 (pl) | 2014-05-07 | 2021-11-08 | Boehringer Ingelheim International Gmbh | Nebulizator |
| CN106255554B (zh) | 2014-05-07 | 2021-05-04 | 勃林格殷格翰国际有限公司 | 容器、喷雾器及用途 |
| CN106232166B (zh) | 2014-05-07 | 2020-04-14 | 勃林格殷格翰国际有限公司 | 喷雾器 |
| RS59613B1 (sr) * | 2014-06-18 | 2020-01-31 | Boehringer Ingelheim Vetmedica Gmbh | Muskarinski antagonisti i njihove kombinacije za lečenje bolesti disajnih puteva kod konja |
| CN108495854B (zh) * | 2015-09-04 | 2021-10-15 | 詹森药业有限公司 | 用于疼痛的治疗性化合物及其合成 |
| CN113292574B (zh) * | 2020-02-21 | 2022-05-03 | 四川大学 | 一类手性多环的托品烷化合物及其制备方法和用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4003270A1 (de) * | 1990-02-03 | 1991-08-08 | Boehringer Ingelheim Kg | Neue treibgase und ihre verwendung in arzneimittelzubereitungen |
| DE4108393A1 (de) * | 1991-03-15 | 1992-09-17 | Boehringer Ingelheim Kg | Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln |
-
2000
- 2000-10-14 DE DE10050994A patent/DE10050994A1/de not_active Withdrawn
-
2001
- 2001-09-28 AU AU1397502A patent/AU1397502A/xx active Pending
- 2001-09-28 TR TR2004/00376T patent/TR200400376T4/xx unknown
- 2001-09-28 ES ES01982374T patent/ES2215147T3/es not_active Expired - Lifetime
- 2001-09-28 SI SI200130085T patent/SI1325001T1/xx unknown
- 2001-09-28 RS YUP-295/03A patent/RS50464B/sr unknown
- 2001-09-28 JP JP2002536281A patent/JP4109106B2/ja not_active Expired - Lifetime
- 2001-09-28 UA UA2003054186A patent/UA73804C2/uk unknown
- 2001-09-28 WO PCT/EP2001/011226 patent/WO2002032899A1/de active IP Right Grant
- 2001-09-28 DK DK01982374T patent/DK1325001T3/da active
- 2001-09-28 AT AT01982374T patent/ATE259805T1/de active
- 2001-09-28 EP EP03023933A patent/EP1382606A3/de not_active Withdrawn
- 2001-09-28 NZ NZ525836A patent/NZ525836A/en not_active IP Right Cessation
- 2001-09-28 IL IL15533401A patent/IL155334A0/xx active IP Right Grant
- 2001-09-28 BR BR0114635-1A patent/BR0114635A/pt not_active Expired - Fee Related
- 2001-09-28 AU AU2002213975A patent/AU2002213975B2/en not_active Expired
- 2001-09-28 CN CNB018171443A patent/CN1275962C/zh not_active Expired - Lifetime
- 2001-09-28 KR KR1020037005256A patent/KR100830359B1/ko not_active IP Right Cessation
- 2001-09-28 SK SK435-2003A patent/SK287138B6/sk not_active IP Right Cessation
- 2001-09-28 HU HU0301203A patent/HUP0301203A3/hu unknown
- 2001-09-28 DE DE50101524T patent/DE50101524D1/de not_active Expired - Lifetime
- 2001-09-28 ME MEP-399/08A patent/MEP39908A/xx unknown
- 2001-09-28 PT PT01982374T patent/PT1325001E/pt unknown
- 2001-09-28 EA EA200300459A patent/EA005816B1/ru not_active IP Right Cessation
- 2001-09-28 PL PL360673A patent/PL207311B1/pl not_active IP Right Cessation
- 2001-09-28 MX MXPA03003160A patent/MXPA03003160A/es active IP Right Grant
- 2001-09-28 CA CA002425557A patent/CA2425557C/en not_active Expired - Lifetime
- 2001-09-28 EP EP01982374A patent/EP1325001B1/de not_active Expired - Lifetime
- 2001-09-28 EE EEP200300151A patent/EE05179B1/xx not_active IP Right Cessation
- 2001-10-02 SA SA01220414A patent/SA01220414B1/ar unknown
- 2001-10-10 UY UY26958A patent/UY26958A1/es not_active Application Discontinuation
- 2001-10-12 MY MYPI20014765A patent/MY127144A/en unknown
- 2001-10-12 AR ARP010104785A patent/AR035589A1/es active Pending
- 2001-10-12 TW TW090125220A patent/TWI306098B/zh not_active IP Right Cessation
- 2001-10-12 PE PE2001001018A patent/PE20020433A1/es not_active Application Discontinuation
-
2003
- 2003-03-28 BG BG107688A patent/BG66225B1/bg active Active
- 2003-04-07 EC EC2003004542A patent/ECSP034542A/es unknown
- 2003-04-10 IL IL155334A patent/IL155334A/en not_active IP Right Cessation
- 2003-04-11 NO NO20031693A patent/NO328207B1/no not_active IP Right Cessation
- 2003-04-11 HR HR20030278A patent/HRP20030278B1/xx not_active IP Right Cessation
- 2003-04-11 ZA ZA200302914A patent/ZA200302914B/en unknown
-
2004
- 2004-05-20 HK HK04103582A patent/HK1060566A1/xx not_active IP Right Cessation
-
2008
- 2008-02-14 JP JP2008033492A patent/JP2008120834A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20031693L (no) | Nye anticholinerge midler som kan anvendes som medikamenter og fremgangsmåte for fremstilling av disse | |
| NO2023030I1 (no) | Apixaban and pharmaceutical acceptable salts thereof | |
| PL401469A1 (pl) | Pochodna azabicykliczna, sposób jej wytwarzania, jej zastosowanie w medycynie oraz zawierajaca pochodna kompozycja | |
| NO20040072L (no) | Nye substituerte benzimidazol-doseringsformer og fremgangsmate for anvendelse av samme | |
| NO20031744D0 (no) | Nye ikke-imadazolforbindelser og farmasöytisk preparat omfattende slike | |
| NO20025133D0 (no) | Nye, lengevirkende betamimetika, fremgangsmÕte for deres fremstilling og deres anvendelse som medikamenter | |
| ATE371647T1 (de) | 3-cyanochinoline, 3-cyano-1,6-naphthyridine und 3-cyano-1,7-naphthyridine als protein- kinaseinhibitoren | |
| DK1345937T3 (da) | Quinuclidincarbamatderivater og deres anvendelse som M3-antagonister | |
| NO20030298D0 (no) | Nye heteroarylderivater og deres anvendelse som farmasöytiske midler | |
| DK1246802T3 (da) | 4-aminopicolinater og deres anvendelse som herbicider | |
| ATE464050T1 (de) | Aripiprazole wirkstoff mit niedriger hygroskopie und verfahren zu ihrer herstellung | |
| AU2002213975A1 (en) | Novel anticholinergic agents that can be used as medicaments and method for the production thereof | |
| NO20030870D0 (no) | Bicykliske heterocykler, medikamenter inneholdende disse, deres anvendelseog fremgansgmåte for fremstilling derav | |
| NO20025357D0 (no) | Antranylamider og deres anvendelse som legemidler | |
| NO20041266L (no) | Piperidinderivater som kan anvendes som CCR5-antagonister | |
| DE60125945D1 (de) | Nasenspüler und dessen auslassstück | |
| NO20035328D0 (no) | Nye forbindelser og preparater som katepsinhibitorer | |
| NO20025504D0 (no) | Nye tiokromanderivater og anvendelse derav som trombininhibitorer | |
| NO20030156L (no) | Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav | |
| FI20000194A0 (fi) | Menetelmä kaupankäynnissä | |
| NO20016404L (no) | Naftyridinderivater, fremgangsmåter for deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse | |
| NO20031108D0 (no) | Farmasöytisk preparat for behandling av hodepine, og fremgangsmåte for fremstilling av preparatet | |
| DK1330453T3 (da) | Indolylpiperidinderivater som antihistamin- og anti-allergimidler | |
| NO20024105D0 (no) | Memnopeptider, fremgangsmåte for deres fremstilling og anvendelse av disse | |
| NO20042022L (no) | Fast legemiddelformulering som inneholder pipiperazinurea-derivat og fremgangsmate for fremstilling av formuleringen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |